A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged ≥65 years with community-acquired pneumonia

2005 ◽  
Vol 27 (8) ◽  
pp. 1251-1259 ◽  
Author(s):  
Andrew F. Shorr ◽  
Neringa Zadeikis ◽  
Jim X. Xiang ◽  
Alan M. Tennenberg ◽  
E. Wes Ely
The Lancet ◽  
2011 ◽  
Vol 377 (9782) ◽  
pp. 2023-2030 ◽  
Author(s):  
Sabine CA Meijvis ◽  
Hans Hardeman ◽  
Hilde HF Remmelts ◽  
Rik Heijligenberg ◽  
Ger T Rijkers ◽  
...  

The Lancet ◽  
2015 ◽  
Vol 385 (9977) ◽  
pp. 1511-1518 ◽  
Author(s):  
Claudine Angela Blum ◽  
Nicole Nigro ◽  
Matthias Briel ◽  
Philipp Schuetz ◽  
Elke Ullmer ◽  
...  

2021 ◽  
pp. dtb-2021-000057

AbstractOverview of: Dinh A, Ropers J, Duran C, et al. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet 2021;397:1195–203.


2002 ◽  
Vol 24 (5) ◽  
pp. 736-751 ◽  
Author(s):  
Mark H. Gotfried ◽  
Dan Dattani ◽  
Ernie Riffer ◽  
Karen J. Devcich ◽  
Todd A. Busman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document